Music Licensing, Inc. (OTC: SONG) Announces Additional Royalty Payment from Listerine® Intellectual Property Stake, $36 Million to $250 Million Acquisition Targets for 2025, and Strategic Investor Relations Initiatives
Music Licensing, Inc. (OTC: SONG) has received another royalty payment from its Listerine® Antiseptic Mouthwash intellectual property stake. The company announced acquisition targets of $36 million to $250 million for 2025, to be funded by Jake P. Noch Family Office, The acquisitions will occur in tranches from $25,000 to several million USD, following the receipt of approximately $24 million in reimbursements under a court-approved 3(a)(10) arrangement. The company plans to enhance investor relations through sponsored research reports, conference participation, and investor outreach. Additionally, Music Licensing is reviewing its Pro Music Rights subsidiary's business model for potential restructuring in 2025.
Music Licensing, Inc. (OTC: SONG) ha ricevuto un altro pagamento di royalty grazie alla sua partecipazione intellettuale nel Listerine® Antiseptic Mouthwash. L'azienda ha annunciato obiettivi di acquisizione tra $36 milioni e $250 milioni per il 2025, finanziati dal Jake P. Noch Family Office. Le acquisizioni avverranno in tranche da $25.000 a diversi milioni di dollari, a seguito del ricevimento di circa $24 milioni in rimborsi sotto un accordo 3(a)(10) approvato dal tribunale. L'azienda intende migliorare le relazioni con gli investitori attraverso rapporti di ricerca sponsorizzati, partecipazione a conferenze e attività di outreach verso gli investitori. Inoltre, Music Licensing sta esaminando il modello di business della sua controllata Pro Music Rights per eventuali ristrutturazioni nel 2025.
Music Licensing, Inc. (OTC: SONG) ha recibido otro pago de regalías por su participación en la propiedad intelectual del enjuague bucal Listerine® Antiseptic. La empresa anunció objetivos de adquisición entre $36 millones y $250 millones para 2025, que serán financiados por la oficina familiar de Jake P. Noch. Las adquisiciones se llevarán a cabo en tramos de $25,000 a varios millones de dólares, tras la recepción de aproximadamente $24 millones en reembolsos bajo un acuerdo 3(a)(10) aprobado por el tribunal. La empresa planea mejorar las relaciones con los inversores a través de informes de investigación patrocinados, participación en conferencias y contacto con los inversores. Además, Music Licensing está revisando el modelo de negocio de su filial Pro Music Rights para una posible reestructuración en 2025.
Music Licensing, Inc. (OTC: SONG)은 Listerine® Antiseptic Mouthwash의 지식 재산권으로부터 또 다른 로열티 지급을 받았습니다. 이 회사는 2025년을 위한 3,600만 달러에서 2억 5천만 달러 사이의 인수 목표를 발표하며, Jake P. Noch 가족 사무실이 자금을 지원할 예정입니다. 인수는 25,000달러부터 수백만 달러까지의 분할로 진행되며, 법원 승인을 받은 3(a)(10) 협정에 따라 약 2,400만 달러의 환급을 받은 후 진행됩니다. 이 회사는 연구 보고서 후원, 컨퍼런스 참가 및 투자자 접촉을 통해 투자자 관계를 강화할 계획입니다. 또한 Music Licensing은 2025년을 위한 Pro Music Rights 자회사의 비즈니스 모델 재구성을 검토하고 있습니다.
Music Licensing, Inc. (OTC: SONG) a reçu un autre paiement de redevances grâce à sa participation intellectuelle dans le Listerine® Antiseptic Mouthwash. L'entreprise a annoncé des objectifs d'acquisition allant de 36 millions à 250 millions de dollars pour 2025, financés par le Jake P. Noch Family Office. Les acquisitions se feront par tranches de 25 000 à plusieurs millions de dollars, après la réception d'environ 24 millions de dollars en remboursements dans le cadre d'un accord 3(a)(10) approuvé par le tribunal. L'entreprise prévoit d'améliorer ses relations avec les investisseurs via des rapports de recherche sponsorisés, une participation à des conférences et un contact avec les investisseurs. De plus, Music Licensing examine le modèle commercial de sa filiale Pro Music Rights en vue d'une éventuelle restructuration en 2025.
Music Licensing, Inc. (OTC: SONG) hat eine weitere Lizenzgebühr von seiner Beteiligung an der Listerine® Antiseptic Mouthwash eingesteckt. Das Unternehmen gab Akquisitionsziele von 36 Millionen bis 250 Millionen Dollar für 2025 bekannt, die durch das Jake P. Noch Family Office finanziert werden sollen. Die Akquisitionen erfolgen in Tranchen von 25.000 bis mehrere Millionen USD, nachdem etwa 24 Millionen USD an Rückerstattungen im Rahmen einer vom Gericht genehmigten 3(a)(10)-Vereinbarung erhalten wurden. Das Unternehmen plant, die Beziehungen zu Investoren durch gesponserte Forschungsberichte, Konferenzteilnahmen und Investoren-Kontakt zu verbessern. Darüber hinaus überprüft Music Licensing das Geschäftsmodell seiner Tochtergesellschaft Pro Music Rights auf mögliche Umstrukturierungen im Jahr 2025.
- Received new royalty payment from Listerine® intellectual property stake
- Planned acquisitions ranging from $36M to $250M for 2025
- Structured acquisition approach in multiple tranches to minimize risk
- Expected $24M in reimbursements through court-approved arrangement
- Family Office funding structure restricts direct cash payments to company
- Acquisition funding dependent on successful block trade executions
- Potential restructuring of Pro Music Rights subsidiary indicates operational challenges
Naples, FL, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Music Licensing, Inc. (OTC: SONG) (“the Company”) is pleased to announce the receipt of another royalty payment from its intellectual property stake in Listerine® Antiseptic Mouthwash. This payment highlights the strength of the Company’s royalty-generating assets and supports its ambitious plans for strategic growth in 2025.
The Company has set acquisition targets ranging from
The acquisitions will occur in tranches ranging from
“Our ongoing royalty payments from the Listerine® stake demonstrate the reliability of our intellectual property investment strategy,” said Jake P. Noch, CEO of Music Licensing, Inc. “Through a compliant funding structure and a disciplined acquisition strategy, we are focused on building a robust and diversified portfolio to enhance shareholder value.”
Jake P. Noch Family Office, LLC plans to commence funding for these acquisitions once it realizes approximately
In addition to its acquisition and funding strategies, Music Licensing, Inc. is taking steps to enhance its investor relations outreach in the coming months. These initiatives include:
- Engaging in sponsored research reports and sponsored analyst coverage to increase visibility among investors.
- Participating in investor conferences to showcase the Company’s strategy and performance to institutional and retail investors.
- Conducting additional regulatory-permitted investor targeting outreach to improve engagement and communication with the investment community.
“As we grow, we recognize the importance of keeping our investors informed and engaged,” added Noch. “By stepping up our investor relations efforts, we aim to ensure that the market has a clear understanding of our strategy, performance, and potential. These initiatives are a vital part of our commitment to transparency and shareholder value creation.”
The Company is also actively reviewing the business model of its wholly owned subsidiary, Pro Music Rights. In 2025, Music Licensing, Inc. may consider restructuring Pro Music Rights to improve operational efficiency and align with evolving market dynamics, further strengthening its position in the intellectual property sector.
“Pro Music Rights has been a cornerstone of our portfolio, and we are committed to ensuring its continued success,” said Noch. “By evaluating its current business model, we aim to identify opportunities to optimize its operations and maximize its contribution to our overall growth.”
Music Licensing, Inc. remains dedicated to providing regular updates on its acquisition strategy, investor relations efforts, and strategic initiatives as part of its ongoing commitment to transparency and shareholder engagement.
About Music Licensing, Inc. (OTC: SONG) (ProMusicRights.com)
Music Licensing, Inc. (OTC: SONG), also known as Pro Music Rights, is a diversified holding company and the fifth public performance rights organization (PRO) formed in the United States. Its licensees include notable companies such as TikTok, iHeart Media, Triller, Napster, 7Digital, Vevo, and many others. Pro Music Rights holds an estimated market share of
Additionally, Music Licensing, Inc. (OTC: SONG) owns royalty stakes in Listerine "Mouthwash" Antiseptic and musical works by artists such as The Weeknd, Justin Bieber, Kanye West, Elton John, Mike Posner, blackbear, Lil Nas X, Lil Yachty, DaBaby, Stunna 4 Vegas, Miley Cyrus, Lil Wayne, XXXTentacion, Jeremih, Ty Dolla $ign, Eric Bellinger, Ne-Yo, MoneyBagg Yo, Halsey, Desiigner, DaniLeigh, Rihanna, and numerous others.
Forward-Looking Statements:
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that, all forward-looking statements involve risks and uncertainties, including without limitation, the ability of Music Licensing, Inc. & Pro Music Rights, Inc. to accomplish its stated plan of business. Music Licensing, Inc. & Pro Music Rights, Inc. believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this press release will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by Pro Music Rights, Inc., Music Licensing, Inc., or any other person.
Non-Legal Advice Disclosure:
This press release does not constitute legal advice, and readers are advised to seek legal counsel for any legal matters or questions related to the content herein.
Non-Investment Advice Disclosure:
This communication is intended solely for informational purposes and does not in any way imply or constitute a recommendation or solicitation for the purchase or sale of any securities, commodities, bonds, options, derivatives, or any other investment products. Any decisions related to investments should be made after thorough research and consultation with a qualified financial advisor or professional. We assume no liability for any actions taken or not taken based on the information provided in this communication.
Contact: investors@ProMusicRights.com
SOURCE: Music Licensing, Inc
FAQ
What are Music Licensing Inc.'s (SONG) acquisition targets for 2025?
How will SONG fund its 2025 acquisitions?
What is SONG's latest development with Listerine royalties?